News · CRISPR/Cas9
130 stories
Aug 14, 26After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?
Aug 14, 26‘We’re not afraid of competition’: BioCryst CEO sets out strategy after scrapping internal discovery
Aug 7, 26STAT+: NIH plans to block international researchers on visas from accessing key funding avenue